# Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders

> **NCT06788119** · NA · RECRUITING · sponsor: **Universitat Jaume I** · enrollment: 158 (estimated)

## Conditions studied

- Anxiety Disorders
- Specific Phobia
- Panic Disorder
- Agoraphobia
- Social Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Cognitive behavioral therapy with in vivo exposure
- **BEHAVIORAL:** Cognitive behavorial therapy with in vivo exposure plus SYMPTOMS-JIT

## Key facts

- **NCT ID:** NCT06788119
- **Lead sponsor:** Universitat Jaume I
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788119, "Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06788119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*